Inclusion Body Myositis Clinical Trials

10 recruiting

Inclusion Body Myositis Trials at a Glance

10 actively recruiting trials for inclusion body myositis are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Early Phase 1 with 1 trial, with the heaviest enrollment activity in Austin, Bethesda, and Bordeaux. Lead sponsors running inclusion body myositis studies include Murdoch University, Austin Neuromuscular Center, and Assistance Publique - Hôpitaux de Paris.

Browse inclusion body myositis trials by phase

Treatments under study

About Inclusion Body Myositis Clinical Trials

Looking for clinical trials for Inclusion Body Myositis? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Inclusion Body Myositis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Inclusion Body Myositis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting

Adult and Juvenile Myositis

DermatomyositisInclusion Body MyositisPolymyositis
National Institute of Environmental Health Sciences (NIEHS)1,200 enrolled4 locationsNCT00017914
Recruiting
Not Applicable

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease

Myasthenia GravisAmyotrophic Lateral SclerosisNeuromuscular Diseases (NMD)+15 more
University of Missouri-Columbia50 enrolled1 locationNCT07478172
Recruiting

Comparison between the Camry and the Jamar Dynamometers in measuring hand grip strength in people with Inclusion Body Myositis

Inclusion Body Myositis
Murdoch University50 enrolled1 locationACTRN12626000086369
Recruiting

MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)

DermatomyositisInflammatory MyopathyInclusion Body Myositis+9 more
Myositis International Health & Research Collaborative Alliance Foundation700 enrolled1 locationNCT07374107
Recruiting
Early Phase 1

Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis

Idiopathic Inflammatory MyopathiesSporadic Inclusion Body Myositis (sIBM)
Austin Neuromuscular Center10 enrolled2 locationsNCT06479863
Recruiting
Phase 2

Ruxolitinib Treatment in Inclusion Body Myositis

Inclusion Body Myositis, Sporadic
Assistance Publique - Hôpitaux de Paris80 enrolled16 locationsNCT06536166
Recruiting

A pilot study to evaluate the impact of an intensive TheraPutty® hand exercise intervention on strength and function in people with Inclusion Body Myositis (IBM)

Inclusion Body Myositis
Murdoch University30 enrolled1 locationACTRN12625000379415
Recruiting
Phase 3

Sirolimus in Inclusion Body Myositis (IBM)

Inclusion Body Myositis
The Perron Institute for Neurological and Translational Science140 enrolled7 locationsACTRN12620001226998
Recruiting

Resistance training with Partial Vascular Occlusion (VOT) in Inclusion Body Myositis (IBM). A single group interventional study: a pilot study to corroborate prior findings of VOT in the IBM population

Inclusion Body Myositis
Sir Charles Gairdner Hospital Physiotherapy Department6 enrolled1 locationACTRN12614000086662
Recruiting

Dysphagia in Inflammatory Muscle Diseases: Answering the Questions Who, Where, Why and What to Do?

Swallowing (dysphagia) problems in patients with Inflammatory muscle diseases (Inclusion body myositis, dermatomyositis and polymyositis
Sir Charles Gairdner Hospital70 enrolled1 locationACTRN12609000671268